News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
101 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32275)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (92)
2 (55)
3 (1)
4 (4)
5 (65)
6 (116)
7 (86)
8 (101)
9 (46)
10 (4)
11 (5)
12 (90)
13 (97)
14 (81)
15 (116)
16 (43)
17 (1)
18 (12)
19 (98)
20 (90)
21 (83)
22 (111)
23 (47)
26 (66)
27 (70)
28 (93)
29 (55)
30 (39)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
26
27
28
29
30
31
FDA
AcelRx announces receipt of Type A FDA meeting minutes and plans to resubmit the DSUVIA New Drug Application in Q2 2018
AcelRx Pharmaceuticals Inc. announced the receipt of the official January 2018 Type A meeting minutes from the U.S. Food and Drug Administration (FDA) relating to AcelRx’s DSUVIA™ New Drug Application (NDA).
March 8, 2018
·
3 min read
Business
Quality Pain Care LLC Offers GAINSWave in Miramar, FL
Quality Pain Care LLC is pleased to announce they now offer GAINSWave™!
March 8, 2018
·
1 min read
BioMidwest
Zimmer Biomet Prices Offering of Senior Notes
Zimmer Biomet Holdings Inc. announced that it has priced an offering of $450 million principal amount of its floating rate senior unsecured notes due 2021 and $300 million principal amount of its 3.700% senior unsecured notes due 2023.
March 8, 2018
·
1 min read
Pharm Country
Next Generation Biologics, Janssen’s Tremfya, Eli Lilly’s Taltz, and Novartis’ Cosentyx, Raising the Bar in Psoriasis Management
A recent study published by Spherix Global Insights reveals that the newest psoriasis entrant, Tremfya, has made substantial gains in penetrating first-line biologic therapy for psoriasis.
March 8, 2018
·
4 min read
BioMidwest
JOMS study: Reconstruction of facial gunshot wounds improved by computer-aided surgery
Using an innovative new protocol employing computer-aided surgery for reconstructing facial gunshot wounds can result in many benefits, including restoration of pre-injury breathing and eating, according to a just published study.
March 8, 2018
·
3 min read
Baylis Medical wins Best Managed Companies award
Baylis Medical Company is proud to announce that it has been named a 2018 winner of Canada’s Best Managed Companies, one of the country’s leading business award programs honouring excellence in Canadian-owned and managed businesses.
March 8, 2018
·
1 min read
Job Trends
Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition
Saranas placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C.
March 8, 2018
·
1 min read
Business
Nobilis Health Reports Fourth Quarter and Full Year 2017 Financial Results
Full year total revenue of $299.7 million, a 4.9% increase over prior year
March 8, 2018
·
26 min read
Business
Walgreens Boots Alliance Appoints James Kehoe Global Chief Financial Officer
Kehoe takes over from George Fairweather, who played a key role in the Walgreens-Alliance Boots merger and subsequent integration and development, and has decided to step down after a combined 16 years in the senior finance leadership position in Walgreens Boots Alliance and legacy companies.
March 8, 2018
·
6 min read
Biotech Bay
Eyenuk, Inc. Receives Health Canada Approval for EyeArt™, an AI-enabled Cloud-based Automated Diabetic Retinopathy Screening Software
Building upon Eyenuk’s successful launch in Europe, this Health Canada license supports Eyenuk’s objective to expand the global availability of EyeArt™ to more clinicians seeking tools for improved screening of diabetic retinopathy in their patients at the point of care.
March 8, 2018
·
4 min read
Previous
7 of 11
Next